Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-01 @ 5:00 PM
Study NCT ID:
NCT03802604
Status:
COMPLETED
Last Update Posted:
2025-09-09
First Post:
2018-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-18
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-15
First Submit QC Date:
None
Study First Post Date:
2019-01-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-09
Last Update Post Date Type:
ESTIMATED